Abstract
If somebody should be called the father of modern dialysis, the honour should go to a Scotsman, Thomas Graham (Figure 1), who lived from 1805–1869. He was appointed Professor of Chemistry at Anderson’s University, Glasgow, in 1830 at the age of 25 (1), moving to the Chair of Chemistry at University College, London, in 1837 and was finally appointed Warden and Master Worker of the Mint, London, in 1855. Graham, an extraordinary genius, laid not only the foundation of what later became colloid chemistry, but also invented a method for separating gases by diffusion, which in later years was used for separating uranium 235 from the 238 isotope.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Munro AC: Thomas Graham (1805–1869). Phil J (Glasgow) 8: 30, 1971
Graham T: Liquid diffusion applied to analysis. Phil Trans Roy Soc London 151: 183, 1861
Abel JJ, Rowntree LC, Turner BB: On the removal of diffusible substances from the circulating blood by means of dialysis. Trans Assoc Am Physicians 28: 51, 1913
Abel JJ, Rowntree LG, Turner BB: On the removal of diffusable substances from the circulating blood of living animals by dialysis. J Pharmacol Exp Ther 5: 275, 1913–1914
Abel JJ, Rowntree LG, Turner BB: Some constituents of the blood. J Pharmacol Exp Ther 5: 611, 1913–1914
Abel JJ, Rowntree LG, Turner BB: Plasma removal with return of corpuscles (plasmaphaeresis). J Pharmacol Exp Ther 5: 625, 1913–1914
Hess CL von, McGuigan H: The condition of sugar in the blood. J Pharmacol Exp Ther 6: 45, 1914–1915
Love GH: Vividiffusion with intestinal membranes. Med Rec (NY) 98: 649, 1920
Necheles H: Ueber dialysieren des strömenden Blutes am Lebenden (On dialysis of the circulating blood in vivo). Klin Wochenschr 2: 1257, 1923 (in German)
Necheles H: Erwiderung zu vorstehenden Bemerkungen (Comment on the previous remarks). Klin Wochenschr 2: 1888, 1923 (in German)
Lim RKS, Necheles H: Demonstration of a gastric secretory excitant in circulating blood by vividialysis. Proc Soc Exp Biol Med 24: 197, 1926
Haas G: Dialysieren des strömenden Blutes am Lebenden (Dialysis of the circulating blood in vivo). Klin Wochenschr 2: 1888, 1923 (in German)
Haas G: Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse (Experiments on cleansing of blood in vivo by means of dialysis). Klin Wochenschr 4: 13, 1925 (in German)
Haas G: Ueber Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse (On experimental cleansing of blood in vivo with dialysis). Naunyn Schmiedebergs Arch Pharmacol 116: 158, 1926 (in German)
Haas G: Ueber Versuche mit Blutwaschung am Lebenden mit Hilfe der Dialyse (On experimental cleansing of blood in vivo with dialysis). Naunyn Schmiedebergs Arch Pharmacol 120: 371, 1927 (in German)
Haas G: Ueber Blutwaschung (On cleansing of blood). Klin Wochenschr 7: 1356, 1928 (in German)
Haas G: Die Methoden der Blutauswaschung (Methods of cleansing of blood). Abderhalden’s Handb Biol Arbeitsmethoden V 8: 717, 1935 (in German)
Philipsson P: Ueber die Verwendbarkeit der Schilfschläuche zur Dialyse (The application of reed stalks to dialysis). Beitr Chem Phys Path 1: 80, 1902 (in German)
Pregl F: Beitrage zur Methodik des Dialysierverfahrens von E. Abderhalden (Contribution to the methodology of the dialysis procedure of E. Abderhalden) Ferm Forsch 1: 7, 1914 (in German)
Benedum J, Weise M: Georg Haas (1886–1971): Sein Beitrag zur Frühgeschichte der künstlichen Niere (Georg Haas: His contribution to the early history of the artificial kidney). Dtsch Med Wochenschr 103: 1674, 1978 (in German)
Benedum J: Georg Haas (1886–1971): Pionier der Hämodialyse (Georg Haas: Pioneer of haemodialysis). Med Hist J 14: 196, 1979 (in German)
Asaba H, Bergström J, Fürst P, Shaldon S, Wilkund S: Treatment of diuretic resistent fluid retention with ultrafiltration. Acta Med Scand 204: 145, 1978
Verbanck J, Schelstraete J, De Paepe M, Hoenich N, Ringoir S: Pure ultrafiltration by repeated puncture of a peripheral armvein as treatment of refractory edema. Int J Artif Organs 3: 342, 1980
Thalhimer W: Experimental exchange transfusion for reducing azotemia. Use of the artificial kidney for this purpose. Proc Soc Exp Biol Med 37: 641, 1937
Kolff WJ: First clinical experience with the artificial kidney. Ann Intern Med 62: 608, 1965
Kolff WJ, Berk HThJ: De kunstmatige nier: een dialysator met groot oppervlak (The artificial kidney: a dialyser with large surface area). Ned Tijdschr Geneeskd 87: 1684, 1943 (in Dutch)
Kolff WJ, Berk HThJ, ter Welle M, van der Ley AJW, van Dijk EC, van Noordwijk J: De kunstmatige nier: een dialysator met groot oppervlak (The artificial kidney: a dialyser with large surface area. Geneesk Gids 21: 409, 1943 (in Dutch)
Kolff WJ, Berk HThJ, ter Welle M, van der Ley AJW, van Dijk EC, van Noordwijk J: The artificial kidney, a dialyzer with a great area. Acta Med Scand 117: 121, 1944
Kolff WJ: Le rein artificiel: un dialyseur à grande surface (The artificial kidney: a dialyser with large surface area). Presse Méd 52: 103, 1944 (in French)
Kolff WJ: De Kunstmatige Nier (The artificial kidney), MD Thesis, University of Groningen, The Netherlands, Kampen, JH Kok NV, 1946 (in Dutch)
Thorwald J: Die Patienten (The Patients). München-Zürich, Droemer-Knauer Verlag 1975, p 99 (in German)
Domingo WR, Klijne W: A photoelectric flame photometer. Biochem J 45: 400, 1949
Murray G, Delorme E, Thomas N: Development of an artificial kidney. Arch Surg 55: 505, 1947
Bywaters EGL, Joekes BM: The artificial kidney: its clinical application in the treatment of traumatic anuria. Proc R Soc Med 41: 411 and 420, 1948
Fishman AP, Kroop JG, Leiter HE, Hyman A: Experiences with the Kolff artificial kidney. Am J Med 7: 15, 1949
De Leeuw NKM, Blaustein A: Studies of blood passed through an artificial kidney. Blood 4: 653, 1949
Darmady EM: Dialysis of blood for the treatment of uraemia. Proc R Soc Med 41: 410 and 418, 1948
Merrill JP: Dialysis in acute renal failure. In: Replacement of Renal Function by Dialysis, chapter 17, Edited by Drukker W, Parsons FM, Mäher JF, Martinus Nijhoff, Medical Division, The Hague, Boston MA, London, 1st edition 1978, p 322
Bull GM, Joekes AM, Lowe KG: Conservative treatment of anuric uraemia. Lancet 2: 229, 1949
Borst JGG: Protein katabolism in uraemia. Effects of proteinfree diet, infections and blood transfusions. Lancet 1: 824, 1948
Kolff WJ: Dialysis in treatment of uremia. Arch Intern Med 94: 142, 1954
Alwall N: On the artificial kidney. I. Apparatus for dialysis of blood in vivo. Acta Med Scand 128: 317, 1947
Alwall N, Norviit L: On the artificial kidney. II. The effectivity of the apparatus. Acta Med Scand (Suppl) 196: 250, 1947
Alwall N: Therapeutic and Diagnostic Problems in Severe Renal Failure, Copenhagen, Munksgaard; Stockholm, Svenska Bokförlaget; Oslo and Bergen, Universitetsforlaget, 1963 p2
Alwall N, Bergsten BWB, Gedda PO, Norviit L, Steins AM: On the artificial kidney. IV. The technique in animal experiments. Acta Med Scand 132: 392, 1949
Alwall N: Experiences with treatment of uremia by dialysis of the blood in vivo (‘artificial kidney’) Twenty-third meeting of the Northern Surgical Association held in Stockholm June 26–28, 1947. Copenhagen, Munksgaard, 1948, p 418
Alwall N, Norviit L, Steins AM: On the artificial kidney. VII. Clinical experiences of dialytic treatment of uremia. Acta Med Scand 132: 587, 1949
Alwall N: Historical Perspective on the Development of Artificial Organs, Lund (Sweden) Gambro AB, 1985
Hamilton DNH: Developing the artificial kidney in Britain: Frank Maudsley Parsons at Leeds. In: The University of Leeds Review, edited by Felsenstein F, vol. 27 1984/85, University Printing Service, p 89
Parsons F: Historical aspects of dialysis. In 10th Ann Symposium on Renal Technology, edited by Lawrence AE Siviter AG, Br Assoc of Renal Technicians, 1986
Parsons FM: Indications for haemodialysis in acute renal failure. In Acute Renal Failure, a Symposium, edited by Shaldon S, Cook GC, Oxford UK, Blackwell Scientific Publications 1964, p 139
Kerr DNS: Twenty five years of haemodialysis, a tribute to the pioneer work of the Belfast renal unit. Ulster Med J 54 (Suppl): 586, 1985
Murray G, Delorme E, Thomas N: Artificial kidney. JAMA 137: 1596, 1948
Von Garrelts B: Twenty-third meeting of the Northern Surgical Association held in Stockholm June 26–28, 1947, Copenhagen, Munksgaard, 1948, p 422
Von Garrelts B: A blood dialyzer for use in vivo. Acta Med Scand 155: 87, 1956
Inouye WY, Engelberg J: A simplified artificial dialyzer and ultrafilter. Surg Forum 4: 438, 1953
Kolff WJ: The artificial kidney past and future. Circulation 15: 285, 1957
Watschinger B, Kolff WJ: Further development of the artificial kidney of Inouye and Engelberg. Trans Am Soc Artif Intern Organs 1: 37, 1955
Kolff WJ, Watschinger B: Further development of a coil kidney. J Lab Clin Med 47: 969, 1956
Michielsen P: A single pass system with recirculation for the twin coil kidney. Proc Eur Dial Transplant Assoc 2: 267, 1965
MacNeill AE, Doyle JE, Anthone R, Anthone S: Technic with a parallel flow straight tube blood dialyzer. NY State J Med 59: 4137, 1959
Doyle JE, Anthone R, Anthone S, MacNeill AE: Treatment of renal failure with a parallel flow, straight tubing blood dialyzer. NY State J Med 59: 4149, 1959
Doyle JE: Extracorporeal Hemodialysis Therapy in Blood Chemistry Disorders. Am Lecture Series no. 453, Springfield, IL, Charles C. Thomas, 1962, p 18
Skeggs LT Jr, Leonards JR: Studies on an artificial kidney. I. Preliminary results with a new type of continuous dialyzer. Science 108: 212, 1948
Skeggs LT Jr, Leonards JR, Heisler CR: Artificial Kidney. II. Construction and operation of an improved continuous dialyzer. Proc Soc Exp Biol Med 72: 539, 1949
Muehrcke RC: Acute Renal Failure. St Louis, The CV Mosby Company 1969, p 277
Mäher JF, Schreiner GE, Waters TJ: Successful intermittent hemodialysis longest reported maintenance of life in true oliguria (181 days). Trans Am Soc Artif Intern Organs 6: 123, 1960
Giovannetti S, Bigalli A, Cioni L, Della Santa M, Ballestri P: Permanent vein cannulation for repeated hemodialysis. Acta Med Scand 173: 1, 1963
Shaldon S, Rosen SM: Technique of refrigerated coil preservation haemodialysis with femoral venous catheterization. Br Med J 2: 411, 1964
Quinton W, Dillard D, Scribner BH: Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 6: 104, 1960
Sinclair ISR, Henderson MA, Simpson DC: Fluon arteriovenous shunt for repeated haemodialysis. Lancet 2: 410, 1961
Quinton WE, Dillard D, Cole JJ, Scribner BH: Possible improvement in the technique of longterm cannulation of blood vessels. Trans Am Soc Artif Intern Organs 7: 60, 1961
Sevitt L, Comty C, Rottka H, Shaldon S: The single break silastic teflon shunt. Proc Eur Dial Transplant Assoc 1: 271, 1964
Shaldon S: Proc Working Conf on Chron Dialysis, Seattle (University of Washington), December 3–5, 1967, p 16
Ramirez O, Swartz C, Onesti G, Mailloux L, Brest AN: The winged inline shunt. Trans Am Soc Artif Intern Organs 12: 220, 1966
Buselmeier TJ, Kjellstrand CM, Ratazzi CC, Simmons RL, Najarian JS: A new subcutaneous prosthetic A–V shunt: advantageous over the standard Quinton-Scribner shunt and AV fistula. Proc Clin Dial Transplant Forum 2: 67, 1972
Wetzeis E: Hämodialyse und Peritonealdialyse (Hemodialysis and Peritoneal dialysis). Berlin, Heidelberg, New York, SpringerVerlag 1969, p 127 (in German)
Scribner BH, Caner JEZ, Buri R, Quinton WE: The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs 6: 88, 1960
Kiil F, (Amundsen B): Development of a parallel flow artificial kidney in plastics. Proc Eur Dial Transplant Assoc (Suppl) 253: 142, 1960
Kiil F, Glover JF Jr: Parallel flow plastic hemodialyzer as a membrane oxygenator. Trans Am Soc Artif Intern Organs 8: 43, 1962
Scribner BH, Buri R, Caner JEZ, Hegstrom R, Burneil JM: The treatment of chronic uremia by means of intermittent dialysis: a preliminary report. Trans Am Soc Artif Intern Organs 6: 114, 1960
Pendras JP, Cole JJ, Tu TH, Scribner BH: Improved technique of continuous flow hemodialysis. Trans Am Soc Artif Intern Organs 7: 27, 1961
Cole JJ, Quinton WE, Williams C, Murray JS, Sherris JC: The pumpless low temperature hemodialysis system. Trans Am Soc Artif Intern Organs 8: 209, 1962
Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH: Hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 7: 136, 1961
Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH: Two years experience with periodical hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 8: 266, 1962
Murray JS, Tu WH, Alberts JB, Burnell JM, Scribner BH: A community hemodialysis center for the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 8: 315, 1962
Brown HW, Maher JF, Lapierre L, Bledsoe FH, Schreiner GE: Clinical problems related to the prolonged artificial maintenance of life by hemodialysis in chronic renal failure. Trans Am Soc Artif Intern Organs 8: 281, 1962
Gonzalez FM, Pabico RL, Brown HW, Maher JF, Schreiner GE: Further experience with the use of routine intermittent hemodialysis in chronic renal failure. Trans Am Soc Artif Intern Organs 9: 11, 1963
Kolff WJ, Nakamoto S, Scudder JP: Experiences with longterm intermittent dialysis. Trans Am Soc Artif Intern Organs 8: 292, 1962
Lindholm DD, Burnell JM, Murray JS: Experience in the treatment of chronic uremia in an outpatient community hemodialysis center. Trans Am Soc Artif Intern Organs 9: 3, 1963
Sherris JC, Cole JJ, Scribner BH: Bacteriology of continuous flow hemodialysis. Trans Am Soc Artif Intern Organs 7: 37, 1961
Fry DL, Hoover PL: Single pass dialysate flow for the Seattle pumpless hemodialysis system. Trans Am Soc Artif Intern Organs 10: 98, 1964
Mion CM, Hegstrom RM, Boen ST, Scribner BH: Substitution of sodium acetate for bicarbonate in the bath fluid for hemodialysis. Trans Am Soc Artif Intern Organs 10: 110, 1964
Mudge GH, Manning JA, Gilman A: Sodium acetate as a source of fixed base. Proc Soc Exp Biol Med 71: 136, 1949
Grimsrud L, Cole JJ, Lehman GA, Babb AL, Scribner BH: A central system for the continuous preparation and distribution of hemodialysis fluid. Trans Am Soc Artif Intern Organs 10: 107, 1964
Scribner BH, Babb AL: Chronic hemodialysis in Seattle 1960–1966, part II. Dial Transplant 11: 324, 1982
Bower JD, Belle CH, Hench ME: Bactericidal properties of the concentrated artificial kidney bath solution. Appl Microbiol 14: 45, 1966
Gutch GF, Swanson JR, Ogden DA: Failure of dialysis concentrate as a bactericidal agent. Proc Clin Dial Transplant Forum 4: 234, 1974
Alberts C, Drukker W: Report on regular dialysis treatment in Europe. Proc Eur Dial Transplant Assoc 2: 82, 1965
Drukker W, Schouten WAG, Alberts C: Report on regular dialysis treatment in Europe, IV, 1968. Proc Eur Dial Transplant Assoc 5: 3, 1969
Shaldon S, Baillod RA, Comty C, Oakley J, Sevitt L: 18 Months experience with a nursepatient operated chronic dialysis unit. Proc Eur Dial Transplant Assoc 1: 233, 1964
Shaldon S, Rae AI, Rosen SM, Silva H, Oakley J: Refrigerated femoral venousvenous haemodialysis with coil preservation for rehabilitation of terminal uraemic patients. Br Med J 1: 1716, 1963
Leading article (anonymous): New developments with artificial kidney. Br Med J 1: 1685, 1963
Shaldon S: The self service approach. Dial Transplant 15: 19, 1986
Nose Y: Discussion. Trans Am Soc Artif Intern Organs 11: 15, 1965
Merrill JP, Schupak E, Cameron E, Hampers CL: Hemodialysis in the home. JAMA 190: 466, 1964
Curtis FK, Cole JJ, Fellows HJ, Tyler LL, Scribner BH: Hemodialysis in the home. Trans Am Soc Artif Intern Organs 11: 7, 1965
Baillod RA, Comty C, Ilahi M, Konotey-Ahulu FID, Sevitt L, Shaldon S: Overnight haemodialysis in the home. Proc Eur Dial Transplant Assoc 2: 99, 1965
Hampers CL, Merrill JP, Cameron E: Hemodialysis in the home a family affair. Trans Am Soc Artif Intern Organs 11: 3, 1965
Scribner BH: Maintenance hemodialysis in perspective - 1969. Proc 4th Congr Nephrol Stockholm 3: 110, edited by Alwall N, Berglund F, Josephson BS: Basel, München, New York, Karger 1970
Gurland HJ, Brunner FP, Chantier C, Jacobs C, Schärer K, Seiwood NH, Spies G, Wing AJ: Combined report on regular dialysis and transplantation in Europe, VI. Proc Eur Dial Transplant Assoc 13: 3, 1976
Brynger H, Brunner FP, Chantier C, Donckerwolcke RA, Jacobs C, Kramer P, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, X, 1979, part I. Proc Eur Dial Transplant Assoc 17: 2, 1980
Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venapuncture and a surgically created arteriovenous fistula. N Engl J Med 275: 1089, 1966
Editorial (anonymous): Hemodialysis using an arteriovenous fistula. N Engl J Med 275: 1134, 1966
Shaldon S: The use of the arteriovenous fistula in home haemodialysis. Proc Eur Dial Transplant Assoc 6: 94, 1969
Gutch CG: Artificial kidneys: problems and approaches. Annu Rev Biophys Bioeng 4: 405, 1975
Del Greco F, Ivanovich P, Krumlovsky FA (editors): Advances in Dialysis. Kidney Int 18 (Suppl 10): 1980
Kolff WJ: The artificial kidney past, present and future. Trans Am Soc Artif Intern Organs 1: 1, 1955
Salisbury PF: History of The American Society for Artificial Internal Organs. Trans Am Soc Artif Intern Organs 6: II, 1960
The Book of Daniel 12: 4. The Holy Bible. Cleveland, New York, World Publishing Company (year of original publication unknown) (cited in ref. 119)
Drukker W: Annual Business Meeting. Proc Eur Dial Transplant Assoc 2: 346, 1965
Drukker W: The birth of the EDTA revisited. Nieren und Hochdruckkrankheiten 15: 309, 1986
Geerlings W, Tufveson G, Broyer M, Brunner FP, Brynger H, Fassbinder W, Rizzoni G, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XVII, 1986. (Available from Ms Sheila R Dykes, Administrator of the EDTA-ERA Registration Committee, St. Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, UK).
Edson H, Keen M, Gotch F: Comparative solute transport and therapeutic effectiveness of multiple point support and standard Kiil hemodialyzers. Trans Am Soc Artif Intern Organs 18: 113, 1972
Von Hartitzsch B, Hoenich NA, Peterson RJ, Buselmeier TJ, Kerr DNS, Kjellstrand CM: Middle molecule clearance in current dialysers. Proc Eur Dial Transplant Assoc 10: 522, 1973
Leonard EF, Bluemle LW Jr: The permeability concept as applied to dialysis. Trans Am Soc Artif Intern Organs 6: 33, 1960
Bluemle LW Jr, Dickson JG Jr, Mitchell J, Podolnick MS: Permeability and hydrodynamic studies on the MacNeillCollins dialyzer using conventional and modified membrane supports. Trans Am Soc Artif Intern Organs 6: 38, 1960
Muldoon JF, Leonard EF: Measurement of dialyzing solution film permeability under idealized conditions. Trans Am Soc Artif Intern Organs 6: 44, 1960
Hoeltzenbein J: Discussion. Trans Am Soc Artif Intern Organs 12: 368, 1966
Drukker W, Jungerius NA, Alberts C: Report on regular dialysis treatment in Europe III. Proc Eur Dial Transplant Assoc 4: 5, 1967
Anderson WW, Mann JB: Kiil versus coil dialysis a comparative clinical study. In: Hemodialysis, Principles and Practice. Edited by Bailey GL, New York and London, Academic Press, 1972, p 373
Stewart RD, Lipps BJ, Baretta ED, Piering WR, Roth DA, Sargent JA: Shortterm hemodialysis with the capillary kidney. Trans Am Soc Artif Intern Organs 14: 121, 1968
Gotch F, Lipps BJ, Weaver J Jr, Brandes J, Rosin J, Sargent JA, Oja P: Chronic dialysis with the hollow fiber artificial kidney (HFAK). Trans Am Soc Artif Intern Organs 15: 87, 1969
Alwall N: A new disposable artificial kidney: experimental and clinical experience. Proc Eur Dial Transplant Assoc 5: 18, 1968
Drukker W: Which membrane? Dial Transplant Int 14: 12B, 142A, 1985
Vanherweghem J-L, Drukker W, Schwarz A: Clinical significance of blood-device interaction in hemodialysis. A review. Int J Artif Organs 10: 219, 1987
Scribner BH: Discussion. Trans Am Soc Artif Intern Organs 11: 29, 1965
Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meterhour hypothesis. Trans Am Soc Artif Intern Organs 17: 81, 1971
Christopher TG, Cambi V, Harker LA, Hurst PE, Popovich RP, Babb AL, Scribner BH: A study of hemodialysis with lowered dialysate flow rate. Trans Am Soc Artif Intern Organs 17: 92, 1971
Babb AL, Farrell PC, Uvelli DA, Scribner BH: Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs 18: 98, 1972
Milutinovic J, Halar EM, Harker LA, Babb AL, Scribner BH: Further experience with hemodialysis at 100 ml/min dialysate flow. Proc Clin Dial Transplant Forum 1: 48, 1971
Ginn HE, Bugel HJ, James L, Hopkins P: Clinical experience with small surface area dialyzers (SSAD). Proc Clin Dial Transplant Forum 1: 53, 1971
Rosenzweig J, Babb AL, Vizzo JF, Ginn HE: Large surface area hemodialysis. Proc Clin Dial Transplant Forum 1: 56, 1971
Funck-Brentano JL: Experience with a new ‘open membrane’. Proc Clin Dial Transplant Forum 1: 80, 1971
Funck-Brentano JL, Sausse A, Man NK, Granger A, Rondon-Nucete M, Zingraff J, Jungers P: Une nouvelle méthode d’hémodialyse associant une membrane à haute perméabilité pour les moyennes molécules et un bain de dialyse en circuit fermé (A new method of haemodialysis with a membrane highly permeable for middle molecules and a closed dialysis fluid circuit). Proc Eur Dial Transplant Assoc 9: 55, 1972 (in French)
Babb AL, Strand MJ, Uvelli DA, Milutinovic J, Scribner BH: Quantitative description of dialysis treatment: a dialysis index. Kidney Int 7 (Suppl 2): S23, 1975
Babb AL, Strand MJ, Uvelli DA, Scribner BH: The dialysis index. A practical guide to dialysis treatment. Dial Transplant 6(9): 9, 1977
Von Hartitzsch B, Hoenich N A, Peterson RJ, Buselmeier TJ, Kerr DNS, Kjellstrand CM: Middle molecule clearance in current dialysers. Proc Eur Dial Transplant Assoc 10: 522, 1973
Kjellstrand CM, Evans RI, Petersen RJ, Rust LW, Shideman J, Buselmeier TJ, Rozelle LT: Considerations of the middle molecule hypothesis. Proc Clin Dial Transplant Forum 2: 127, 1972
Shaldon S, Florence P, Fontanier C, Polito C, Mion C: Comparison of two strategies for short dialysis using 1 m2 and 2 m2 surface area dialysers. Proc Eur Dial Transplant Assoc 12: 596, 1975
Middle Molecules in Uremia and Other Diseases. Proceedings of the Symposium on Present Status and Future Orientation of Middle Molecules in Uremia and Other Diseases, Avignon, France, November 28–29, 1980. Artif Organs 4, Suppl 1981
Rosenzweig J, Babb AL, Vizzo JF, Ginn HE: Large surface area hemodialysis. Proc Clin Dial Transplant Forum 1: 56, 1971
Mirahmadi KS, Kay JH, Miller JH, Gorman JT, Rosen SM: Clinical evaluation of patients dialysed with double Gambro 4 hours, 3 times per week. Proc Eur Dial Transplant Assoc 11: 121, 1974
Cambi V, Savazzi G, Arisi L, Bignardi L, Bruschi L, Rossi E, Migone L: Short dialysis schedules (SDS)Finally ready to become routine? Proc Eur Dial Transplant Assoc 11: 112, 1974
Proceedings of the Conference on Natural and Synthetic Membranes, Edited by Saravis C, Gershenkorn K, Brown ME. DHEW (NIH) publ 1967
Leonard EF, Colton CK, Craig LD, Gessler RM, Klein E, Lontz JF, Lyman DJ, Mason RG, Nossel HL: Evaluation of membranes for hemodialyzers. Report of the Membrane Evaluation Study Group for the Artif Kidney-Chronic Uremia Program of NIAMDD 1974, DHEW publ no (NIH) 74: 605
Barbour BH, Bernstein M, Cantor PA, Fischer BS, Stone W Jr: Clinical use of NISR 440 polycarbonate membrane for hemodialysis. Trans Am Soc Artif Intern Organs 21: 144, 1975
Langlois R, Kaye M: Two year clinical trial of polycarbonate membranes for hemodialysis. Dial Transplant 8: 1111, 1979
Babb AL, Farrell PC, Strand MJ, Uvelli DA, Milutinovic J, Scribner BH: Residual renal function and chronic hemodialysis therapy. Proc Clin Dial Transplant Forum 2: 142, 1972
Von Hartitzsch B: The middle molecule in present day hemodialysis. Proc Clin Dial Transplant Forum 2: 149, 1972
Reiger J, Quellhorst E. Lowitz HD, Kong RG, Scheler F: Ultrafiltration for middle molecules in uraemia. Proc Eur Dial Transplant Assoc 11: 158, 1974
Milutinovic J, Cutler RE, Hoover P, Meysen B, Scribner BH: Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 8: 185, 1975
Widerøe TE, Grimsrud L, Berg KJ, Godal A, Jansen R, Jorstad S: A mathematical singlepool model for short time haemodialysis. Proc Eur Dial Transplant Assoc 11: 136, 1974
Keshaviah P, Collins A: Rapid highefficiency bicarbonate hemodialysis. Trans Am Soc Artif Intern Organs 32: 17, 1986
Maiorca R, Castellani A, Migozzi G, Panzetta GO, Usberti M: Short time personalised dialysis: good results in spite of high levels of small and middle molecules. Proc Eur Dial Transplant Assoc 11: 146, 1974
Cambi V, Garini G, Savazzi G, Arisi L, David S, Zanelli P, Bono F, Gardini F: Short dialysis. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 20: 111, 1983
Daugirdas JT, Ing TS, Rumayn HH, Weber DS, Chen WT, Gandhi VC, Reid HH, Hano JE: Two-hour high surface area hemodialysis: a feasibility study. Int J Artif Organs 4: 13, 1981
Rotellar E, Martinez ME, Plans A, Ferragut A: Haemodialysis: only six hours once a week. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 22: 312, 1985
Rotellar E, Martinez E, Samsó JM, Barrios J, Simo R, Mulero JF, Perez MD, Bandres S, Pinol J: Large surface hemodialysis. Artif Organs 10: 387, 1986
Rotellar E, Martinez E, Samsó JM, Barrios J, Simo R, Mulero JF, Perez D, Bandres S, Pinol J: Why dialyze more than 6 hours a week? Trans Am Soc Artif Intern Organs 31: 538, 1985
Drukker W, Alberts Chr, Jungerius NA: Dialysate glucose concentration and plasma osmolality during haemodialysis in acute renal failure. Proc Eur Dial Transplant Assoc 2: 1, 1965
Cambi V, Buzio C, Arisi L, Calderini C, David S, Manari A, Bono F, Zanelli P: Vascular stability and middle molecules removal in hypertonic haemodiafiltration. Proc Eur Dial Transplant Assoc 18: 681, 1981
Von Albertini B, Miller JH, Gardner PW. Shinaberger JH: Highflux hemodiafiltration: under six hours/week treatment. Trans Am Soc Artif Intern Organs 30: 227, 1984
Miller JH, Von Albertini B, Gardner PW, Shinaberger JH: Technical aspects of highflux hemodiafiltration for adequate short (under 2 hours) treatment. Trans Am Soc Artif Intern Organs 30: 377, 1984
ManjiT, Maeda K, Kawaguchi S, Kobayashi K, Ohta K, Saito A, Amano I, Shimoji T, Fujisaki J: Short time dialysis with 2 m2 hollow fibre kidney. Proc Eur Dial Transplant Assoc 11: 153, 1974
Odaka M, Tabata Y, Kobayashi H, Nomura Y, Soma M, Hirasawa H, Sato H, Suenaga E, Nabeta K: Three-hour maintenance dialysis combining direct haemoperfusion and haemodialysis. Proc Eur Dial Transplant Assoc 13: 257, 1976
Bergstrom: Citing Hess Thaysen in Uraemic Toxins. Proc Eur Dial Transplant Assoc 12: 579, 1975 (page 584)
Kramer P, Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Jacobs C, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XII, 1981. Proc Eur Dial Transplant Assoc 19: 4, 1982
Laurent G, Calemard E, Charra B: Long dialysis: a review of fifteen years experience in one centre (1968–1983). Proc Eur Dial Transplant Assoc-Eur Ren Assoc 20: 122, 1983
Wizemann V, Mueller K, Kramer W, Schütterle G: Ten years experience with short dialysis: A decade of cardiovascular complications. Nephrol Dial Transplant 1: 100, 1986 (Abstract)
Raja R, Kramer M, Goldstein S, Caruana R, Lerner A: Short hemodialysis 10year followup. Trans Am Soc Artif Intern Organs 32: 374, 1986
Reiger J, Quellhorst E, Lowitz HD, Kong RG, Scheler F: Ultrafiltration for middle molecules in uraemia. Proc Eur Dial Transplant Assoc 11: 158, 1974
Milutinovic J, Cutler RE, Hoover P, Meysen B, Scribner BH: Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 8: 185, 1975
Gotch F, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 28: 526, 1985
Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Vanel T: Hémodialyse, syndrome du canal carpien et substance amyloide (Haemodialysis, carpal tunnel syndrome and amyloid material). Nouv Presse Méd 9: 1715, 1980 (in French)
Gejyo F, Yamada T, Odani S, Magakawa Y, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K: A new form of amyloid protein associated with hemodialysis was identified as β2 microglobulin. Biochem Biophys Res Comm 129: 701, 1985
Gotch FA: A quantitative evaluation of small and middle molecule toxicity in therapy of uremia. Dial Transplant 9: 183, 1980
Bricker NS: On the pathogenesis of the uremic state. An exposition of the ’trade of hypothesis’. N Engl J Med 286: 1093, 1972
Bergström J, Fürst P: Uremic middle molecules. Clin Nephrol 5: 143, 1976
Massry SG, Goldstein DA: Role of parathyroid hormone in uremic toxicity. Kidney Int 13 (Suppl 8): S39, 1978
Massry SG, Goldstein DA: The search for uremic toxin(s) ‘X’, ‘X’ = PTH. Clin Nephrol 11: 181, 1979
Bogin E, Massry SG, Levi J, Djaldetti M, Bristol G, Smith J: Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69: 1017, 1982
Bogin E, Massry SG, Harary I: Effect of parathyroid hormone on rat heart cells. J Clin Invest 67: 1215, 1981
Bergström J, Fürst P: Uraemic toxins. In: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff Publ., 1983, p 354
Giovannetti S, Biagini M, Cione L: Evidence that methylguanidine is retained in chronic renal failure. Experientia 24: 341, 1968
Giovannetti S, Barsotti G: Dialysis of methyl guanidine. Kidney Int 6: 177, 1974
Balestri PL, Barsotti G, Camici M, Giovannetti S: High plasma fibrinogen levels and reduced fibrinolytic activity in dogs intoxicated with methyl guanidine. Clin Nephrol 2: 81, 1974
Fürst P, Asaba M, Gordon A, Zimmerman L, Bergström J: Middle molecules in uraemia. Proc Eur Dial Transplant Assoc 11: 417, 1974
Kersting F, Brass H: The effects of uraemic compounds on oxygen consumptions and mechanical activity of isolated guinea pig hearts. Proc Eur Dial Transplant Assoc 13: 472, 1976
Asaba H, Bergström J, Fürst P, Oulès R, Zimmerman L: Accumulation and excretion of middle molecules. Proc Eur Dial Transplant Assoc 13: 481, 1976
Dzúrik R, Adam J, Valončovâ E, Rezniček J, Zvara V: The effect of haemodialysis on blood peptide levels. Proc Eur Dial Transplant Assoc 8: 167, 1971
Dzúrik R, Božek P, Řtezníček J, Oborníkovâ A: Blood level of middle molecular substances during uraemia and haemodialysis. Proc Eur Dial Transplant Assoc 10: 263, 1973
Dall’Aglio P, Buzio C, Cambi V, Arisi L, Migone L: La rétention de moyennes molecules dans le sérum urémique (Retention of middle molecules in uraemic serum). Proc Eur Dial Transplant Assoc 9: 409, 1972 (in French)
Migone L, Dall’Aglio P, Buzio C: Middle molecules in uremic serum, urine and dialysis fluid. Clin Nephrol 3: 82, 1975
Funck-Brentano JL, Man NK, Sausse A: Effect of more porous dialysis membranes on neuropathic toxins. Kidney Int 7 (Suppl2): S52, 1975
Man NK, Ferlain B, Paris J, Werner G, Sause A, Funck-Brentano JL: An approach to ‘middle molecules: identification in artificial kidney dialysate, with reference to neuropathy prevention. Trans Am Soc Artif Intern Organs 19: 320, 1973
Man NK, Granger A, Rondon-Nucete M, Zingraff J, Jüngers P, Sausse A, Funck-Brentano JL: One year followup of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc 10: 236, 1973
Man NK, Cueuille G, Zingraff J, Drüeke T, Jungers P, Sausse A, Billon JP, Funck-Brentano JL: Investigations on clinicochemical correlations in uraemic polyneuritis. Proc Eur Dial Transplant Assoc 11: 214, 1974
Bergström J, Gordon A, Fürst P, Ryhage R: A study of uremic toxicology. Proc 7th Annu Contractors Conf Artif Kidney - Chronic Uremia Program of NIAMDD, edited by Krueger KK, DHEW publ no (NIH) 75: 248, 1974, p 19
Bergström J: Uraemic toxicity. Proc Eur Dial Transplant Assoc 12: 579, 1975
Fürst P, Zimmerman L, Bergström J: Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol 5: 178, 1976
Bergström J, Fürst P, Zimmerman L: Uremic middle molecules exist and are biologically active. Clin Nephrol 11: 229, 1979
Zimmerman L, Baldesten A, Bergström J, Fürst P: Isotachophoretic separation of middle molecule peptides in uremic body fluids. Clin Nephrol 13: 183, 1980
Bergström J, Fürst P: Uraemic toxins, in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 1st edition, The Hague, Boston, London, Martinus Nijhoff, 1978, p 334
Schoots A, Mikkers F, Cramers C, De Smet R, Ringoir S: Uremic toxins and the elusive middle molecules. Nephron 38: 1, 1984
Vanholder R, Schoots A, Cramers C, De Smet R, van Landschoot N, Wizemann V, Botella J, Ringoir S: Hippuric acid as a marker. In: Uremic Toxins, edited by Ringoir S, Vanholder R, Massry S, New York, Plenum Press, 1987
Boumendil-Podevin EF, Podevin RA, Richet G: Uricosuric agents in uremic sera. Identification of indoxylsulfate and hippuric acid. J Clin Invest 55: 1142, 1975
MacNamara PJ, Lalka D, Gibaldi M: Endogenous accumulation products and serum protein binding in uremia. J Lab Clin Med 98: 730, 1981
Gulyassy PF, Bottini AT, Stanfel LA, Jarrard EA, Depner TA: Isolation and chemical identification of inhibitors of plasma ligand binding. Kidney Int. 30: 391, 1986
Vanholder P, Van Landschoot N, De Smet R, Ringoir S: Inhibition of drug protein binding during chronic renal failure. Kidney Int. 31: 221, 1987 (Abstract)
Charra B, Calemard E, Uzen M, Terrat JC, Laurent G: Carpal tunnel syndrome, shoulder pain and amyloid deposits in longterm haemodialysis patients. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 291, 1984
Bardin T, Kuntz D, Zingraff J, Noel JH, Droz D, Drüeke T, Funck Brentano JL, Vantelon J, Hiernaux P, Barbanel C, Lucas P: Synovial amyloidosis and beta2 microglobulin in longterm hemodialysis patients. Arthritis Rheum 29: 453, 1986
Shirahama T, Cohen AS, Skinner M: Hemodialysis-associated amyloid of ß2-microglobulin nature. In: Amyloidosis, edited by Makkink J, van Rijswijk MH, Dordrecht, Boston, Lancaster, Martinus Nijhoff 1986, p 83
Bardin T, Zingraff J, Kuntz D, Drüeke T: Dialysisrelated amyloidosis. Nephrol Dial Transplant 1: 151, 1986
Jadoul M, Maldague B, Vandenbroucke JM, van Ypersele de Strihou C: The natural history of dialysis associated amyloid osteoarthropathy. The role of the dialysis membranes. Nephrol Dial Transplant 1: 105, 1986 (Abstract)
Karlsson FA, Wibell L, Evrin PE: β2-microglobulin in clinical medicine. Scand J Clin Lab Invest 40 (Suppl 154): 40, 1980
Vandenbroucke JM, Van Ypersele de Strihou C: Relationship between membrane characteristics and dialysis induced changes in β2-microglobulin levels. Nephrol Dial Transplant 1: 105, 1986
Bergström J, Wehle B: No change in corrected β2-microglobulin concentration after Cuprophane haemodialysis. Lancet 1: 628, 1987
Lyman D: Membranes, in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 97
Ota K, Okazawa T, Kumagaya E, Fujii Y, Kinura M, Nagras Y, Tsukamoto H, Tanzawa H, Sakai Y: Polymethylmethacrylate capillary kidney highly permeable to middle molecules. Proc Eur Dial Transplant Assoc 12: 559, 1975
Man NK, Granger A, Rondon-Nucete M, Zingraff J, Jungers P, Sausse A, Funck-Brentano JL: One year followup of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc 10: 236, 1973
Funck-Brentano JL, Man NK, Sausse A: Effect of more porous dialysis membrane on neuropathic toxins. Kidney Int 7: 52, 1974
Funck-Brentano JL, Man NK: The polyacrylonitrile membrane; use in dialysis with the Rhodial system. Use in haemofiltration. in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 275
Gohl H, Konstatin P, Gullberg CA: Hemofiltration membranes. Contrib Nephrol 32: 20, 1982
Hoenich NA, Kerr DNS: Dialysers. in: Replacement of Renal function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983 p 118
Pizziconi VB, Dorson WJ Jr, Breillat J, Hyde GM, Aniuk LM, Walsh SA, Bland LA, Brady RL: Factors affecting complement activation and neutropenia during dialysis using Cuprophane membranes, asaio J 7: 64, 1984
Mito M, Niskimura S, Kawai M, Nose Y, Kawamura T, Yoshimoto C: On extracorporeal circulation of membrane organs (liver, kidney). Sogoigaku 17: 538, 1960 (cited in reference 242)
Kaplow LS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1135, 1968
Papadimitriou M, Baker LRI, Seitanidis B, Sevitt LH, Kulatilake AE: White blood count in patients on regular haemodialysis. Br Med J 4: 67, 1969
Smith EKM, Jobbins K: Observations on neutropenia associated with haemodialysis. Br Med J 4: 70, 1969
Gral Th, Schroth Ph, DePalma JR, Gordon A: Leukocyte dynamics with three types of hemodialyzers. Trans Am Soc Artif Intern Organs 15: 45, 1969
Toren M, Goffinet J A, Kaplow LS: Pulmonary bed sequestration of neutrophils during hemodialysis. Blood 36: 337, 1970
Brubaker LH, Nolph KD: Mechanisms of recovery from neutropenia induced by hemodialysis. Blood 38: 623, 1971
Brubaker LH, Jensen D, Johnson L, Nothum R, Nolph K: Kinetics of stagnatedinduced neutropenia during hemodialysis. Trans Am Soc Artif Intern Organs 18; 305, 1972
Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacobs HS: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879, 1977
Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacobs HS: Complement and leukocytemediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769, 1977
Craddock PR, Hammerschmidt DE: Complement mediated granulocyte activation and down-regulation during hemodialysis. asaio J 7: 50, 1984
Chenoweth DE: Biocompatibility of hemodialysis membranes. Evaluation with C3a anaphylatoxin radioimmunoassays. asaio J 7: 44, 1984
Sherlock JJ, Ledwith JW, Letteri J: Hypoventilation and hypoxemia during hemodialysis: reflex response to removal of C02 across the dialyzer. Trans Am Soc Artif Intern Organs 23: 406, 1977
Aurigemma NM, Feldman NT, Gotlieb M, Ingram RH, Lazarus JM, Lowrie EG: Arterial oxygenation during hemodialysis. N Engl J Med 297: 871, 1977
Patterson RW, Nissenson AR, Miller J, Smith RT, Narins RG, Sullivan SP: Hypoxemia and pulmonary gas exchange during hemodialysis. J Appl Physiol Respir Environ Exercise Physiol 50: 259, 1981
Xabte B, Carter R, Shamebo M, Veicht J, Boulton Jones JM: Dialysis induced hypoxemia. Clin Nephrol 18: 120, 1982
Schaefer K, von Herrath D, Hüfler M: Stable PO2 during hemofiltration in spite of a drop in leukocytes. Nephron 32: 377, 1982 (Letter to the editor)
Romaldini H, Rodriguez-Roisin R, Lopez FA, Ziegler TW, Bencowitz HZ, Wagner PD: The mechanisms of arterial hypoxemia during hemodialysis. Annu Rev Respir Dis 129: 780, 1984
Dolan MJ, Whipp BJ, Davidson WD, Weitzman RE, Wasserman K: Hypopnea associated with acetate hemodialysis: carbon dioxide flow dependent ventilation. N Engl J Med 305: 72, 1981
Klinkmann H: Biocomptability. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 22: 223, 1985
Ringoir S, Vanholder R: An introduction to biocomptability. Artif Organs 10: 20, 1986
Knudsen F, Nielsen AH, Pedersen JO, Jersild C: Haemodialysis induced activation of complement, relates also to individual responsiveness. Int J Artif Organs 8: 233, 1985
Wegmüller E, Montandon A, Nydegger A, Descoeudres C: Biocomptability of different hemodialysis membranes: activation of complement and leukopenia. Int J Artif Org 9: 85, 1986
Levett DL, Woffinden C, Bird AG, Hoenich NA, Ward MK, Kerr DNS: Complement activation in haemodialysis: a comparison of new and re-used dialysers. Int J Artif Organs 9: 97, 1986
Göhl H, Schaefer K, Gullberg CA: Hemofiltration with different type of membranes. Proc Eur Soc Artif Organs 6: 180, 1979
Hörl WH, Schaefer RM, Heidland A: Effect of different dialysers on proteinases and proteinase inhibitors during hemodialysis. Am J Nephrol 5: 320, 1985
Bosch Th, Schmidt B, Spencer PC, Samtleben W, Pelger M, Baurmeister U, Gurland J: Ex vivo biocomptability evaluation of a new modified cellulose membrane. Proc Int Soc Artif Organs 1985 (in press)
Falkenhagen D, Zinner G, Falkenhagen U, Ahrenholz P, Holtz M, Behm E, Klinkmann H: A modified cellulose membrane (MC) with reduced complement activation. Kidney Int 28: 331, 1985 (Abstract)
Peterson PA, Evrin PE, Berggard L: Differentiation of glomerular, tubular and normal proteinuria. Determinations of urinary excretion of β2 microglobulin, albumin and total protein. J Clin Invest 48: 1189, 1969
Bienenstock J, Poortman J: Renal clearance of 15 proteins in renal disease. J Lab Clin Med 75: 297, 1970
Maack TH: Renal handling of low molecular weight proteins. Am J Med 58: 57, 1975
Röckel A, Gilge U, Ohl B, Liewald A, Heidland A: Contr Nephrol 32: 40, 1982
Messner RP: β2microglobulin: an old molecule assumes a new look. J Lab Clin Med 104: 141, 1984
Gejyo F, Homma N, Suzuki Y, Arakawa M: Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing longterm hemodialysis. N Engl J Med 314–585, 1986
Vincent C, Révillard JP, Galland M, Traeger J: Serum beta-2 microglobilin in hemodialyzed patients. Nephron 21: 260, 1978
Forêt M, Milongo R, Meftahi H, Dechelette E, Hachache T, Kuentz F, Renversez JC, Cordonnier D: Plasma levels of β2microglobulin in a population of 151 patients on haemodialysis. Nephrol Dial Transplant 1: 105, 1986 (Abstract)
Bommer J, Seelig HP, Seelig R, Ritz E: β2microglobulin (β2m) levels in haemodialysed patients. Nephrol Dial Transplant 1: 106, 1986
Chanard J, Lavaud S, Toupance O, Melin JP, Gillery P: β2microglobulin associated amyloidosis in chronic haemodialysis patients. Lancet 1: 1212, 1986
Floege J, Granolleras C, Deschodt G, Branger B, Oulès R, Shaldon S, Koch KM: β2microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transplant 1: 107, 1986 (Abstract)
Ackrill P, Robinson EL, Hill K, McClure JC: Removal of β2microglobulin in the relief of shoulder pain in longterm haemodialysis patients. Nephrol Dial Transplant 1: 58, 1986 (Abstract)
Higgins MR, Grace M, Bettcher KB, Silverberg DS, Dossetor JB: Blood access in hemodialysis. Clin Nephrol 6: 473, 1976
Bell PRF, Caiman KC: Surgical Aspects of Haemodialysis. Edinburgh, London, Churchill Livingstone, 1974
Foran RF, Shore E, Levin PM, Freiman RL: Vascular access for hemodialysis, in: Clinical Aspects of Uremia and Dialysis, edited by Massry SG, Sellers AL, Springfield IL, Charles C. Thomas, 1976, p 504
Ramirez O, Swartz C, Onesti G, Mailloux L, Brest AN: The winged in line shunt. Trans Am Soc Artif Intern Organs 12: 220, 1966
Thomas GI: A large-vessel applique A-V shunt for hemodialysis. Trans Am Soc Artif Intern Organs 15: 288, 1969
Thomas GI: The femoral shunt today. Dial Transplant 2(1): 23, 1973
Buselmeier TJ, Kjellstrand CM, Simmons RL, Duncan DA, Von Hartitzsch B, Rattazzi LC, Leonard AS; Najarian JS: A totally new subcutaneous prosthetic arteriovenous shunt. Trans Am Soc Artif Intern Organs 19: 25, 1973
Buselmeier TJ, Kjellstrand CM, Quinton WE, Von Hartitzsch B, Meyer RM, Shideman JR, Bosl BM, Toledo LH, Spanos PK, McCosh TM, Simmons RL, Najarian JS: The Buselmeier shunt. Dial Transplant 3(1): 30, 1974
May J, Tiller D, Johnson J, Stewart J, Sheil AGR: Saphenous vein arteriovenous fistula in regular dialysis treatment. N Engl J Med 280: 770, 1969
Chinitz JL, Yokoyama T, Bower R, Swartz C: Selfsealing prosthesis for arteriovenous fistula in man. Trans Am Soc Artif Intern Organs 18: 452, 1972
Chinitz J, Bower R, Yokoyama T, Del Guercio E, Kim K, Swartz C: Further experience with a self-sealing prosthesis for A-V fistula. Abstracts Am Soc Artif Intern Organs 2: 12, 1973
Richie RE, Johnson K, Walker PJ, Staab EV, Ginn HE: Use of bovine xenograft for problems in vascular access. Abstracts Am Soc Artif Intern Organs 2: 54, 1973
Vanderwerff BA, Rattazzi LC, Katzman HA, Schild AF: Three year experience with bovine graft arteriovenous (AV) fistulas in 100 patients. Trans Am Soc Artif Intern Organs 21: 296, 1975
Beemer RK, Hayes JF: Hemodialysis using a mandril grown graft. Trans Am Soc Artif Intern Organs 19: 43, 1973
Flores L, Dunn I, Frumkin E, Forte R, Requena R, Ryan J, Knopf M, KirschnerJ, Levowitz BS: Dacron arteriovenous shunts for vascular access in hemodialysis. Trans Am Soc Artif Intern Organs 19: 33, 1973
Baker LD Jr, Johnson JM, Goldfarb D: Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for chronic hemodialysis. Trans Am Soc Artif Intern Organs 22: 382, 1976
Kaplan MS, Mirahmadi KS, Winer RL, Gorman JT, Dabirvaziri N, Rosen SM: Comparison of ’PTFE’ and bovine grafts for blood access in dialysis patients. Trans Am Soc Artif Intern Organs 22: 388, 1976
Buselmeier TJ, Rynasiewicz JJ, Sutherland DER, Howard KJ, David TD, Mauer SM, Simmons RL, Najarian JS, Kjellstrand CM: A prosthesis for blood access in patients with thrombosis of peripheral vasculature. Dial Transplant 6 (8): 48, 1977
Mindich BP, Silverman MJ, Elguezabal A, Levowitz BS: Umbilical cord vein fistula for vascular access in hemodialysis. Trans Am Soc Artif Intern Organs 21: 273, 1975
Kester RC: Vascular access for the problem patient. In Dialysis Review, edited by Davison AM, Tunbridge Wells, Kent, UK, Pitman Medical Publishing Co Ltd, 1978, p 106
Brunner FP, Brynger H, Chantler C, Donkerwolcke RA, Hathway RA, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe IX. Proc Eur Dial Transplant Assoc 16: 3, 1979
Golding AL, Nissenson AR, Higgins R, Raible D: Carbon transcutaneous access device (CTAD). Trans Am Soc Artif Intern Organs 26: 105, 1980
Martinez FJ, Cosentino LC: Blood access without skin puncture. Trans Am Soc Artif Intern Organs 27: 308, 1981
Reed WP, Light PD, Sadler JH, Ramos E: Alternative vascular access in patients lacking veins for standard arteriovenous fistulae. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 257, 1984
Bonalumi U, Simoni GA, Friedman D, Borzone E, Griffanti-Bartoli F: Initial experience with Hemasite vascular access device for maintenance haemodialysis. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 262, 1984
Smits PJH, Slooff MJH, Lichtendahl DHE, Vanderhem GK: The Biocarbon® vascular access device (DiaTAB®) for haemodialysis. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 267, 1984
Uldall PR, Dyck RF, Woods F, Merchant N, Martin GS, Cardella CT, Sutton D, deVeber GA: A subclavian cannula for temporary vascular access of hemodialysis or plasmapheresis. Dial Transplant 8: 963, 1979
Uldall PR, Woods F, Merchant N, Bird M, Chrichton E: Two years experience with the subclavian cannula for temporary vascular access for hemodialysis and plasmapheresis. Proc Clin Dial Transplant Forum 9: 32, 1979
Uldall PR, Woods F, Merchant N, Chrichton E, Carter H: A doublelumen subclavian cannula (DLSC) for temporary hemodialysis access. Trans Am Soc Artif Intern Organs 26: 91, 1980
Kopp KF, Gutch CF, Kolff WJ: Single needle dialysis. Trans Am Soc Artif Intern Organs 18: 75, 1972
Keshaviah PR, Shaldon S: Haemodialysis monitors and monitoring. in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 223
Ringoir S, de Broe M, Cardon M, van Waelighem JP, Boone L: New pump system for one needle hemodialysis. Eur Dial Transplant Assoc (Abstract) 10: 200, 1973
Vanholder R, Hoenich N, Piron M, Billiouw JM, Ringoir S: Haemodialysis in a single and two needle vascular access system: a comparative review. Proc Eur Dial Transplant Assoc-Eur Renal Assoc 20: 176, 1983
Bergström J, Asaba H, Fürst P, Oulds R: Dialysis, ultrafiltration and blood pressure. Proc Eur Dial Transplant Assoc 13: 293, 1976
Shaldon S: Discussion Proc Eur Dial Transplant Assoc 13: 300, 1976
Jones EO, Ward MK, Hoenich NA, Kerr DNS: Separation of dialysis and ultrafiltration Does it really help? Proc Eur Dial Transpl Assoc 14: 160, 1977
Ivanovich P, Huang C, Stefanovie N, Del Greco F: A useful adjunct to dialysis. Proc Eur Dial Transplant Assoc 14: 605, 1977
Blaney TL, Lindan O, Sparks RE: Adsorption: a step toward a wearable artificial kidney. Trans Am Soc Artif Intern Organs 12: 7, 1966
Jützler GA, Keller HE, Klein J, Carius J, Floss K, Dijckmans J, Fürsattel L, Leppla W: Physico-chemical investigations in regeneration of dialysis fluid. Proc Eur Dial Transplant Assoc 3: 265, 1966
Twiss EE, Paulssen MMP: Dialysissystem incorporating the use of activated charcoal. Proc Eur Dial Transplant Assoc 3: 262, 1966
Van Leer E: Hemodialyse met Koolstofadsorptie (Haemodialysis with charcoal adsorption). MD Thesis 1970 Univ. of Rotterdam, Drukkerij BronderOffset NV (in Dutch)
Gordon A, Greenbaum MA, Marantz LB, McArthur MJ, Maxwell MH: A sorbent-based low volume recirculating dialysate system. Trans Am Soc Artif Intern Organs 15: 347, 1969
Gordon A, Gral T, DePalma JR, Greenbaum MA, Marantz LB, McArthur MJ, Maxwell MH: A sorbent-based low volume dialysate system: preliminary studies in human subjects. Proc Eur Dial Transplant Assoc 7: 63, 1970
Gordon A, Better OS, Greenbaum MA, Marantz LB, Gral T, Maxwell MH: Clinical maintenance hemodialysis with a sorbent-based low volume dialysate regeneration system. Trans Am Soc Artif Intern Organs 17: 253, 1971
Greenbaum MA, Gordon A: A regenerative dialysis supply system. Dial Transplant 1 (1): 18, 1972
Drukker W: Introduction to the Redy system. Two long-term patients. Nierenu Hochdruckkrankheiten 5, (Suppl): 3, 1976
Drukker W, Parsons FM, Gordon A: Practical application of dialysate regeneration: the Redy system, in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition The Hague, Boston, London, Martinus Nijhoff, 1978, p 244
Briefel GR, Hutchisson JT, Galonsky RS, Hessert RL, Friedman EA: Compact travel hemodialysis system. Proc Clin Dial Transplant Forum 5: 61, 1975
Jacobsen SC, Stephen RL, Bulloch EC, Luntz RD, Kolff WJ: A wearable artificial kidney: functional description of hardware and clinical results. Proc Clin Dial Transplant Forum 5: 65, 1975
Stephen RL, Jacobsen SC, Atkin Thor E, Kolff WJ: Portable wearable artificial kidney (WAK) initial evaluation. Proc Eur Dial Transplant Assoc 12: 511, 1975
Delano B, Friedman EA: Regular dialysis treatment. The portable suitcase kidney, in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 1st edition, The Hague, Boston, London, Martinus Nijhoff, 1978, p 431
Kolff WJ: The future of dialysis. The WAK. in:Replacement of Renal Function by Dialysis chapter 42, edited by Drukker W, Parsons FM, Maher JF, 1st edition, The Hague, Boston, London, Martinus Nijhoff, 1978, p 708
Scribner BH: Substitution of bicarbonate for acetate in the dialysate for the care of a critically ill patient. Dial Transplant 6(3): 26, 1977
Samar RE: Bicarbonate and acetate hemodialysis. Contemp Dial, August 1981, p 10
Tolchin DO: Acetate metabolism and high efficiency hemodialysis. Int J Artif Organs 2: 1, 1979
Gotch FA, Sargent JA, Keen M, Lam M, Prowitt M: The solute kinetics of intermittent dialysis therapy. Proc 11th Annu Contractor s Conf Artif Kidney Program of NIAMDD, edited by Mackey BB. DHEW publication no (NIH) 79–144, 1978, p 110
Muirhead EE, Reid AF: A resin artificial kidney. J Lab Clin Med 33: 841, 1948
Yatzidis H: A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications, its use as an active artificial kidney. Proc Eur Dial Transplant Assoc 1: 83, 1964
Smakman R, Van Doom AWJ, van Berlo A: Promising in vitro results with a new urea sorbent. Life Support Systems (Suppl 2): 264, 1986
Smakman R, Van Doom AWJ: Urea removal by means of direct binding. Clin Nephrol 26 Suppl. 1: S58, 1986
Chang TMS: Micro capsule artificial kidney in replacement of renal function: with emphasis on adsorbent hemoperfusion. in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JM 1st edition The Hague, Boston, London, Martinus Nijhoff, 1978, p 217
Winchester J: Evolution of artificial organs: Extracorporeal removal of drugs. Artif Organs 10: 316, 1986
Winchester JF, Apiliga MT, Mackay JM, Kennedy AC: Haemodialysis with charcoal haemoperfusion. Proc Eur Dial Transplant Assoc 12: 526, 1975
Winchester JF, Apiliga MT, Kennedy AC: Short term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients. Kidney Int 10 (Suppl 7): S315, 1976
Winchester JF: Symposium on sorbents in uremia: Part 4. Comparison of charcoal hemoperfusion with hemodialysis. Dial Transplant 6(9): 46, 1977
Ballardie FW, Kerr DNS, Tennent G, Pepys MB: Haemodialysis versus CAPD: equal disposition to amyloidosis? Lancet 1: 795, 1986 (Letter to the Editor)
Kanwashi N, Tsuchiya T, Sugiyama M, Nishiki M, Ochi K: Elimination of low molecular weight proteins during hemoperfusion of dialysis patients using a urethane sheet embedded with powdered charcoal. Trans Am Soc Artif Intern Organs 32: 425, 1986
Chang TMS: Haemoperfusion over microencapsulated adsorbent in a patient with hepatic coma. Lancet 2: 1371, 1972
Williams R: Approaches to the development of artificial liver support, in: Artificial Organs, edited by Kennedy RM, Courtney JM, Gaylor JDS, Gilchrist T, London and Basingstoke, Macmillan Press, 1977, p 403
Winchester JF: Hemoperfusion. in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston MA, Lancaster, Martinus Nijhoff, 1983, p 316
Henderson LW, Besarab A, Michaels A, Bluemle LW Jr: Blood purification by ultrafiltration and fluid replacement (diafiltration). Trans Am Soc Artif Intern Organs 12: 216, 1967
Brull L:L’ultrafiltration in vivo (Ultrafiltration in vivo). C R Soc Biol (Paris) 99: 1607, 1928 (in French)
Manis T, Friedman EA: Dialytic therapy for irreversible uremia. N Engl J Med 301: 1254, 1321, 1979
Hamilton R, Ford C, Colton C, Cross R, Steinmuller S, Henderson L: Blood cleansing by diafiltration in uremic dog and man. Trans Am Soc Artif Intern Organs 17: 259, 1971
Henderson LW, Livoti LG, Ford CA, Kelly AB, Lysaght MJ: Clinical experience with intermittent hemodiafiltration. Trans Am Soc Artif Intern Organs 19: 119, 1973
Henderson LW, Colton CK, Ford C: Kinetics of hemodiafiltration. II Clinical characterization of a new blood cleansing modality. J Lab Clin Med 85: 372, 1975
Quellhorst E, Rieger J, Doht B, Beckmann H, Jacob I, Kraft B, Mietzsch G, Scheler F: Treatment of chronic uraemia by an ultrafiltration kidney. First clinical experience. Proc Eur Dial Transplant Assoc 13: 314, 1976
Quellhorst EA: Ultrafiltration and haemofiltration, practical applications, in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 265
Henderson LW, Ford C, Bluemle LW, Bixler HJ: Uremic blood cleansing by diafiltration using a hollow fiber ultrafilter. Trans Am Soc Artif Intern Organs 16: 107, 1970
Baldamus CA, Schoeppe W, Koch KM: Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population. Proc Eur Dial Transplant Assoc 15: 228, 1978
Shaldon S, Beau MC, Claret G, Deschodt G, Oules R, Ramperez P, Mion H, Mion C: Haemofiltration with sorbent regeneration of ultrafiltrate: first clinical experience in end stage renal disease. Proc Eur Dial Transplant Assoc 15: 220, 1978
Kramer P, Wigger W, Matthaei D, Scheler F: Arteriovenous hemofiltration. A new and simple method for overhydrated patients resistant to diuretics. Klin Wochenschrift 55: 1121, 1977
Kaplan AE: Clinical trials with predilution and vacuum suction. Enhancing the efficiency of the CAVH treatment. Trans Am Soc Artif Organs 32: 49, 1986
Major RH: A History of Medicine II, Springfield, IL, Charles C. Thomas, 1954, p 916
Schwab PJ, Fahey JL: Treatment of Waldenstrom macroglob ulinemia by plasmapheresis. N Engl J Med 263: 574, 1960
Rees AJ: Plasma exchange: principles and practice, in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 872
Samtleben W, Blumenstein M, Gurland HJ: Membrane plasma separation: advantages and hazards. Eur Dial Transplant Assoc Abstracts XVIIth Congress, Prague 1980, p 84
Sprenger K, Franz HE: Membrane plasma separation (MPS): procedural recommendations. Proc Eur Dial Transplant Assoc 17: 353, 1980
Omokawa S, Malchesky PS, Sakamoto H, Flynn A, Lofters MA, Nosé Y: Changes in interleukin-1 during membrane plasmapheresis. Trans Am Soc Intern Artif Organs 32: 392, 1986
Peters DK, Rees AJ, Lockwood CM: Plasma exchange in glomerular and related autoallergic diseases. Proc Eur Dial Transplant Assoc 14: 409, 1977
Houwert DK, Kater L, Hene RJ, Struyvenberg A: Plasma exchange in immune complex disease. Proc Eur Dial Transplant Assoc 16: 520, 1979
Ota K, Amemiya H, Sugino N, Abe M, Ono T, Kowai S, Yamana T: Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 26: 406, 1980
International symposium on plasma exchange, abstracts. Nieren u Hochdruckkrankheiten 9: 136, 1980
Balow JE: Plasmapheresis and application in treatment of renal disorders. Artif Organs 10: 324, 1986
Lysaght MJ, Samtleben W, Schmidt B, Gurland HJ: Closed loop plasmapheresis. In: Therapeutic Hemapheresis, edited by MacPherson JL, Kaspirin DO, Boca Raton, FL, CCR Press, 1985, p 138
Smit JW, Kayashima K, Kutsume C, Abe Y, Matsubara A, Malchesky PS, Krakauer RS, Nosé Y: Cryopheresis: immunochemical modulation and clinical response in autoimmune disease. Trans Am Soc Intern Artif Organs 28: 391, 1982
Lockwood CM, Rees AJ, Peason TA, Evans D, Peters DK: Immunosuppression and plasma exchange in the treatment of Goodpasture’s syndrome. Lancet 1: 711, 1976
Pusey CD, Lockwood CM, Peters DK: Plasma exchange and immunopressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Int J Artif Organs 6: 15, 1983
Anonymous: Hazards of apheresis. Lancet 2: 1025, 1982 (Editorial)
Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697, 1974
Bagdade JD, Porte D Jr, Bierman EL: Hypertriglyceridemia: a metabolic consequence of chronic renal failure. N Engl J Med 279: 181, 1968
Bagdade JD, Shafrir E, Wilson DE: Mechanism(s) of hyperlipidemia in chronic uremia. Trans Am Soc Artif Intern Organs 22: 42, 1976
Savdie E, Gibson JC, Crawford GA, Simons LA, Mahony JF: Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia. Kidney Int 18: IIA, 1980
Bagdade JD: Hyperlipidemia and atherosclerosis in chronic dialysis patients, in:Replacement of Renal Function by Dialysis, 2nd edition edited by Drukker W, Parsons FM, Maher JF, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 588
Gnasso A, Haberbosch W, Augustin J, Ritz E: Abnormal lipoprotein metabolism in incipient renal failure. Proc Eur Dial Transplant Assoc-Eur Renal Assoc 22: 1129, 1985
Heuck LCh, Ritz E: Hyperlipoproteinemia in renal insufficiency. Nephron 25: 1, 1980
Swamy AP, Cestero RVM, Campbell RG, Freeman RB: Long term effect of dialysate glucose on the lipid levels of maintenance hemodialysis patients. Trans Am Soc Artif Intern Organs 22: 54, 1976
Gonzalez FM, Pearson JE, Garbus SB, Holbert RD: On the effects of acetate during hemodialysis. Trans Am Soc Artif Intern Organs 20a: 169, 1974
Boyle IT: Vitamin D and the kidney. Proc Eur Dial Transplant Assoc 12: 113, 1975
Pappenheimer AM, Wilens SL: Enlargement of parathyroid glands in renal disease. Am J Pathol 11: 73, 1935
Pappenheimer AM: Effect of reduction of kidney substance upon parathyroid glands and skeletal tissue. J Exp Med 64: 965, 1936
Liu SH, Chu HI: Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (AT10) and iron. Medicine (Baltimore) 22: 103, 1943
Nicolaysen R: Studies upon the mode of action of vitamin D3. Ill The influence of vitamin D on the absorption of calcium and phosphorus in the rat. Biochem J 31: 122, 1937
Bauer GCH, Carlsson A, Lindquist B: Evaluation of accretion, resorption and exchange reactions in the skeleton. Kungliga Fysiografiska, Sallskapet I Lund Forhandlinger 25: 3, 1955
Lund J, Deluca HF: Biologically active metabolite of vitamin D3 from bone, liver and blood serum. J Lipid Res 7: 739, 1966
Trummel GL, Raisz LG, Blunt JW: 25Hydroxycholecalciferol: stimulation of bone resorption on tissue culture. Science 163: 1450, 1969
DeLuca HF: The kidney as an endocrine organ for the production of 1, 25hydroxyvitamin D3, a calciummobilizing hormone. N Engl J Med 298: 359, 1973
Bhattacharyya MH, Deluca HF: The regulation of rat calciferol 25hydroxylase. J Biol Chem 248: 2969, 1973
Fraser DR, Kodicek E: Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 228: 764, 1970
Kodicek E: Recent advances in vitamin D metabolism. 1, 25 dihydroxycholecalciferol, a kidney hormone controlling calcium metabolism. Clinics in Endocrinology and Metabolism 1 no. 1 edited by Mclntyre I, London, Philadelphia, Toronto, Saunders Comp Ltd, 1972, p 305.
Holick MF, Schnoes HK, Deluca HF: Identification of 1, 25 dihydroxycholecalciferol; a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci USA 68: 803, 1971
Holick MF, Schnoes HK, Deluca HF: Identification of 1, 25 dihydroxycholecalciferol: a metabolite of vitamin D active in intestine. Biochemistry 10: 2799, 1971
Reeve J: Therapeutic applications of vitamin D analogues. Br Med J 2: 888, 1979
Velentzas C, Oreopoulos DG: 1, 25-dihydroxyvitamin D3 and osteomalacia: some unanswered questions. Int J Artif Organs 3: 313, 1980
Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DNS, Herrington J, Goode GL: Osteomalacic dialysis osteodystrophyevidence for a water borne aetiological agent, probably aluminium. Lancet 1: 84, 1978
Marsden SNE, Parkinson IS, Ward MK, Ellis HA, Kerr DNS: Evidence for aluminium accumulation in renal failure. Proc Eur Dial Transplant Assoc 16: 588, 1979
Alfrey AC, Miskell JM, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH: Syndrome of dispraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18: 257, 1972
Spofforth J: Case of aluminium poisoning. Lancet 1: 1301, 1921
Alfrey AC, Legendre GR, Kaehny WD: The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294: 184, 1976
Parkinson IS, Beckett A, Ward MK, Feest TG, Hoenich N, Strong A, Kerr DNS: Aluminium removal from water supplies. Proc Eur Dial Transplant Assoc 15: 586, 1978
Flendrig JA, Kruis H, Das AH: Aliminium intoxication: the cause of dialysis dementia? Proc Eur Dial Transplant Assoc 13: 355, 1976
Flendrig JA, Kruis H, Das AH: Aliminium and dialysis dementia. Lancet 1: 1235, 1976
Elliott HL, Macdougall AI: Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc 15: 157, 1978
Platts MM, Goode GC, Hislop JS: Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J 2: 657, 1977
Davison AM, Giles GR: The effect of transplantation on dialysis encephalopathy. Proc Eur Dial Transplant Assoc 16: 407, 1979
Wing AJ, Brunner FP, Brynger H, Chantler C, Donckerwolcke RA, Gurland HJ, Jacobs C, Kramer P, Selwood H: Dialysis dementia in Europe (Report of the Registration Committee of the European Dialysis and Transplant Association). Lancet 2: 190, 1980
Pierides AM, Edwards JWG, Cullum UX Jr, McCale JT, Ellis HA: Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int 18: 115, 1980
Short AIK, Winney RJ, Robson JS: Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Proc Eur Dial Transplant Assoc 17: 226, 1980
Kaehny WD, Alfrey AC, Holman RE, Shorr WJ: Aluminum transfer during hemodialysis. Kidney Int 12: 361, 1977
Gacek EM, Babb AL, Uvelli DA, Fry DL, Scribner BH: Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum. Trans Am Soc Artif Intern Organs 25: 409, 1979
Berlyne GM, Ben-Ari J, Pest D, Weinberger J, Stern M, Gilmore GR, Levine R: Hyperaluminaemia from aluminium resins in renal failure. Lancet 2: 494, 1970
Berlyne GM: Aluminum toxicity in renal failure. Int J Artif Organs 3: 60, 1980
Ulmer DD: Toxicity from aluminum antacids (Editorial). N Engl J Med 294: 184, 1976
Dewberry FL, McKinney PD, Stone WJ: The dialysis dementia syndrome: report of fourteen cases and review of the literature, asaio J 3: 102, 1980
Bournerias F, Monnier N, Reveillaud RJ: Risk of orally administered aluminium hydroxide and results of withdrawal. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 20: 207, 1983
Graf H, Stumvoll HK, Meisinger V, Kovarik J, Woll A, Pinggera WF: Aluminum removal by hemodialysis. Kidney Int 19: 587, 1981
Slatopolsky F, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315: 157, 1986
Raine AEG, Oliver DO: Management of hyperphosphataemia in renal dialysis patients. Lancet 1: 633, 1987
Schneider H, Kulbe KD, Weber H, Streicher E: High effective aluminium free phosphate binder. In vitro and in vivo studies. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 20: 725, 1983
Levick SE: Dementia from aluminum pots? (Letter to the editor). N Engl J Med 303: 164, 1980
Trapp GA, Cannon JB: Aluminum pots as a source of dietary aluminum (Letter to the editor). N Engl J Med 304: 172, 1981
Koning JH: Aluminum pots as a source of dietary aluminum (Letter to the editor). N Engl J Med 304: 172, 1981
Platts MM, Anastassiades E: Dialysis encephalopathy: precipitating factors and improvement in prognosis. Clin Nephrol 15: 223, 1981
Cournot-Witmer G: Aluminum osteopathy. Contr Nephrol 38: 59, 1984
Botella J, Callego JL, Fernandez-Fernandez J, Sans-Guajardo D, de Miguel A, Ramos J, Franco P, Enriques R, Sanz-Moreno C: The bone scan in patients with aluminium-associated bone disease. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 403, 1984
Vanherweghem J-L, Schoutens A, Bergman P, Dhaene M, Goldman M, Fuss M, Kinnaert P: Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey of dialysis osteodystrophy. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 431, 1984
Hodge KC, Day JP, O’Hara M, Ackrill P, Raison AJ: Critical concentrations of aluminium in water used for dialysis. Lancet 2: 802, 1981
Eschbach JW: Hematologic problems of dialysis patients, in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston MA, Lancaster, Martinus Nijhoff, 1983, p 630
Zins B, Drüeke T, Zingraff J, Bererhi L, Kreis H, Naret C, Dilons S, Castaigne JP, Peteriongo F, Casadevall N, Varet B: Erythropoietin treatment in anaemic patients on haemodialysis. Lancet 2: 1329, 1986
Erslev A: Erythropoietin coming of age. N Engl J Med 316: 101, 1987 (Editorial)
Winnearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM: Effects of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2: 1175, 1986
Eschbach JW, Egrie JC, Downing MR, Boowne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. N Engl J Med 316: 73, 1987
Blumberg BS, Alter HJ, Visnich S: A ’new’ antigen in leukemia sera. JAMA 191: 541, 1965
Blumberg BS: Australia antigen, hepatitis and leukaemia. Tokyo J Med Sci 76: 1, 1968 (cited in ref. 296)
Drukker W, Alberts C, Ode A, Roozendaal KH, Wilmink J: Report on regular dialysis treatment in Europe, II, 1966. Proc Eur Dial Transplant Assoc 2: 90, 1966
Blumberg BS, Gerstley BJS, Hungerford DA, London WT, Sutnick AI: A serum antigen (Australia antigen) in Down’s syndrome, leukemia and hepatitis. Ann Intern Med 66: 924, 1967
London WT, Difiglia M, Sutnick AI, Blumberg BS: Hepatitis in hemodialysis unit: Australia antigen and host response. N Engl J Med 281: 511, 1969
Sutnick AI, Millman I, London WT, Blumberg BS: The role of Australia antigen in viral hepatitis and other diseases. Annu Rev Med 23: 161, 1972
Grob PJ, Bishof B, Naeff F: A cluster of hepatitis B transmitted by a physician. Lancet 2: 1218, 1981
Jacobs C, Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Kramer P, Selwood NH, Wing AJ, Blake PH: Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc 18: 2, 1981
Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV: Transfusion associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292: 767, 1975
Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y: Clinical and serological analysis of transfusion-associated hepatitis. Lancet 2: 838, 1975
Alter HJ, Purcell RH, Holland PV, Popper H: Transmissible agent in nonA, nonB hepatitis. Lancet 1: 460, 1978
Tabor E, Drucker JA, Hoofnagle JH, Apryl M, Gerety RJ, Sieff LB, Jackson DR, Barker LF, Pineda-Tamondong G: Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1: 463, 1978
Vitviski L, Prince AM, Trepo C, Brotman B: Detection of virusassociated antigen in serum and liver of patients with non-A, non-B hepatitis. Lancet 2: 1263, 1979
Galbraith RM, Dienstag JL, Purcell RH, Gower PH, Zuckerman AJ, Williams R: NonA, nonB hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet 1: 951, 1979
Shirachi R, Shiraishi H, Tateda A, Kikuchi K, Ishida N: Hepatitis C antigen in nonA, nonB post transfusion hepatitis. Lancet 2: 853, 1978
Hepatitis and the Treatment of Chronic Renal Failure. Report of the Advisory Group 1970–1972, chairman: Lord Rosenheim, Dept of Health and Social Security, Scottish Home and Health Dept, Welsh Office
Advies inzake de Logistieke Consequenties van het Rapport van de Gezondheidsraad betreffende Maatregelen ter Profylaxe van Serumhepatitis. (Recommendations concerning the logistic consequences from the report of the Dutch Health Council relating to the prophylaxis of serum hepatitis). Centrale Raad voor de Volksgezondheid, Rijswijk 1975 (in Dutch)
Zuckerman AJ: Hepatitis Associated Antigen and Viruses Amsterdam, London, North-Holland Publishing Co, 1972, p 12
Le Bouvier GL: The heterogeneity of Australia antigen. J Infect Dis 123: 671, 1971
Magnius LO, Espmark JA: New specifities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 109: 1017, 1972
Raimondo G, Smedile A, Gallo L, Babbo A, Ponzetto A, Rizetto M: Multicentre study of HBV-associated delta infection and liver disease in drug addicts. Lancet 1: 249, 1982
Editorial (anonymous): Delta agent a virus in disguise? Lancet 1: 259, 1982
Leading article (anonymous): Hightitre hepatitis B immune globulin. Br Med J 1 : 241, 1976
Robinson WS, Lutwick LI: The virus of hepatitis, type B, (Part I) N Engl J Med 295: 1168, 1976
Robinson WS, Lutwick LI: The virus of hepatitis type B Part II. N Engl J Med 295: 1232, 1976
Kiernan TW, Ramgopal M: Viral hepatitis: progress and problems. Med Clin North Am 63: 611, 1979
Wands JR, Kolff R, Isselbacher KJ: Acute viral hepatitis, in: Harrison’s Principles of Internal Medicine, 9th edn International Students Edition, edited by Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD, New York, McGraw-Hill Book Company, 1980, p 1466
Prince AM, Szmuness W, Mann MK: Hepatitis B immune globulin: Final report of a controlled, multicenter trial of efficacy in prevention of dialysis associated hepatitis. J Infect Dis 137: 131, 1978
Zuckerman AJ: Why the world needs a hepatitis vaccine. New Scientist 88: 167, 1980
Krugman S, Giles JP, Hammond J: Viral hepatitis, type B (MS2 strain) studies on active immunization. JAMA 217: 41, 1971
Purcell RH, Gerin JL: Hepatitis B subunit vaccine. A preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci 270: 395, 1975
Maupas P, Goudeau A, Coursaget P, Drucker J, Bagros P: Hepatitis B vaccine: efficacy in highrisk settings, a two year study. Intervirology 10: 196, 1978
Maupas P, Goudeau A, Coursaget P, Drucker J, Barin F, André M: Immunization against hepatitis B in man: a pilot study of two years duration, in: Viral Hepatitis, edited by Vyas GN, Cohen SN, Schmidt R, Philadelphia, Franklin Institute Press, 1978, p 539
Crosnier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I medical staff, II, haemodialysis patients. Lancet 1: 455 and 797, 1981
Szmuness W, Stevens CE, Harley EJ, Zano EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A: Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303: 833, 1980
Dienstag JL: Toward control of hepatitis B (editorial). N Engl J Med 303: 874, 1980
Szmuness W, Stevens CE, Oleszko WR, Goodman A: Passiveactive immunisation against hepatitis B: immunogenicity studies in adult Americans. Lancet 1: 575, 1981
Leading article (anonymous): Immunisation against hepatitis B. Br Med J 281: 1585, 1980
Wing AJ, Broyer M, Brunner FP, Brynger H, Challah S, Donckerwolcke RA, Gretz N, Jacobs C, Kramer P, Selwood NH: Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 20: 61, 1983
Kramer P, Broyer M, Brunner FP, Brynger H, Challah S, Oulès R, Rizzoni G, Selwood NH, Wing AJ, Balés E: Combined report on regular dialysis and transplantation in Europe XIV, 1983. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 21: 51, 1984
Brunner FP, Broyer M, Brynger H, Challah S, Fassbinder W, Oulès R, Rizzoni G, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe XV, 1984. Proc Eur Dial Transplant Assoc-Eur Ren Assoc 22: 5, 1985
Jilg W, Schmidt M, Zoulek G, Lorbeer B, Wilske B, Deinhardt F: Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 2: 1174, 1984
Ambrosch F, Kremsner P, Wiederman G, Thisch-Niggemeyer W, Kunz C, André FE, Safary A: Boosting properties of recombinant DNA hepatitis B vaccine. Lancet 1: 1101, 1986
Valenzuela P, Gray P, Quiroga M, Zaldmar J, Goodman HM, Rutten WJ: Micleotide sequence of the gene coding for the major protein of hepatitis B surface antigen. Nature 280: 815, 1979
Valenzuela P, Medina A, Rutten WJ, Ammerer G, Hall BD: Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347, 1982
Anonymous: Recombinant hepatitis B vaccine. Med Letter 28: 117, 1986
Blumberg BS, London WT: Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med 304: 782, 1981 (Editorial)
Bradbeer C: HIV and lifestyle. Br Med J 294: 5, 1987
Kingsley LA, Kaslow R, Rinaldo Jr CR, Detre K, Odaka N, VanRaden M, Detels R, Polk BV, Chmiel J, Kelsey SF, Ostrow D, Visscher B: Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Lancet 1: 345, 1987
Smith T: Aids: a doctor’s duty. Br Med J 294: 6, 1987
Wallis C, Thompon D: You haven’t heard anything yet’. Health officials wrestle with onslaught of history’s newest epidemic. Time Magazine 129, no. 7: 30, 1987
Dept. of Health and Social security: Latest figures in AIDS in the UK. Lancet 1: 400, 1987
Yarchoan R, Weinhold KJ, Lyerly HK, Gelmann E, Blum RM, Shearer GM, Mitsuya H, Collins JM, Meyers CE, Klecker RW, Markham PD, Durack DT, Lehrman SN, Barry DW, Fischl MA, Gallo RC, Bolognesi DP, Broder S: Administration of 3’Azido-3’deoxythymidine, an inhibitor of HTLV III/LAV replication to patients with AIDS or AIDS related complex. Lancet 1: 575, 1986
Anonymous: Azidothymidine for AIDS. Med Letter 28: 107, 1986
Polakoff S: Dialysis associated hepatitis, in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 659
Geddes AM: Risk of AIDS to health care workers. Br Med J 292: 711, 1986 (Leading article)
Sande MA: Transmission of AIDS. The case against casual contagion. N Engl J Med 314: 380, 1986
Incidence and risk of transmission of HTLV3 infection to staff at a London hospital 1982–’85. J Hosp Infect 6 (Suppl. C): 15, 1985
Almeida JD, Kulatilake AE, Mackay DH, Shackman R, Chisholm GD, MacGregor AB, O’Donoghue EPN, Waterson AP: Possible airborne spread of serum-hepatitis virus within a haemodialysis unit. Lancet 2: 849, 1971
Thölen VH, Strieker E, Feer H, Massini MA, Staub H: Über die Anwendung der künstlichen Niere bei Schizophrenie und Myasthenia gravis (The application of the artificial kidney in cases of schizophrenia and myasthenia gravis). Dtsch Med Wochenschr 85: 1012, 1960 (in German)
Wagemaker H, Cade R: The use of hemodialysis in chronic schizophrenia. Am J Psychiatry 134: 6, 1977
Cade R, Wagemaker H: Hemodialysis as treatment for chronic schizophrenia. Abstracts Am Soc Artif Intern Organs 7: 7, 1978
Wagemaker H, Cade R: The use of hemodialysis in fourteen chronic schizophrenics. Abstracts Am Soc Artif Intern Organs 7: 62, 1978
Palmour RM, Ervin FR, Wagemaker H, Cade R: Characterization of a peptide derived from the serum of psychiatric patients. Abstracts Ann Meeting Soc Neuroscience, 1977
Kolff WJ: Dialysis of schizophrenics. Weird and novel applications of dialysis, hemofiltration, hemoperfusion and peritoneal dialysis: witchcraft? Artif Organs 2: 277, 1978
Gurland HJ: Combination of hemodialysis and hemoperfusion used in conventional dialyser format in the treatment of uremia. Proc 12th Annu Contractor’s Conf Artif Kidney-Chronic Uremia Program of NIAMDD, edited by Mackey BB, DHEW Publication nr. (NIH) 81–1979, 1979, p 279
Twardowski ZJ: Abatement of psoriasis and repeated dialysis. Ann Intern Med 86: 510, 1977
Buselmeier TJ, Dahl MV, Kjellstrand CM, Goltz RW: Dialysis therapy for psoriasis. JAMA 240: 1270, 1978
Kramer P: Dialysis for psoriatic patients. Proc 11th Ann Contractor’s Conf Artif Kidney Program NIAMDD, edited by Mackey BB, DHEW Publication no. (NIH) 79–1442, 1978, p 217
Korz R, Klein H, Genth E: Myasthenia gravis und Lupus erythematosus Nephritis (Myasthenia gravis and lupus erythematosus nephritis). Dtsch Med Wochenschr 103: 1485, 1978 (in German)
Gurland HJ: Is blood purification suitable for an effective cure of psoriasis? Paper presented at the 2nd symposium on chronic renal failure, Prague, March 1979
Burton BT, Kirschman GH: Demographic analysis: end stage renal disease and its treatment in the United States. Clin Nephrol 11: 47, 1979
Waterfall WK: Dialysis and transplantation. Br Med J 281: 726, 1980
Relman AS, Rennie D: Treatment of end stage renal disease. Free but not equal (Editorial). N Engl J Med 303: 996, 1980
Anonymous: Health care Financing Administration, Dept. of Health and Human Services: Medicare and non/medicare patients receiving dialysis treatments as of December 31, 1985. Dial Transplant 15: 544, 1986
Drukker W: Haemodialysis: a historical review, in:Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 41
Editorial (anonymous): Ethics and the nephrologist. Lancet 1: 594, 1981
Wing AJ, Brunner FP, Brynger HOA, Jacobs C, Kramer P: Comparative review between dialysis and transplantation, in: Replacement of Renal Function by Dialysis, edited by Drukker W, Parsons FM, Maher JF, 2nd edition, Dordrecht, Boston, Lancaster, Martinus Nijhoff, 1983, p 851
Evans RW, Blagg CR: Treatment of end-stage renal disease (Letter to the editor). N Engl J Med 304: 357, 1981
Relman AS, Rennie D: Treatment of end-stage renal disease (Reply). N Engl J Med 304: 357, 1981
Iglehart K: Funding the endstage renaldisease program. N Engl J Med 306: 492, 1982
Parsons FM, Brunner FP, Burck HC, Gräser W, Gurland HJ, Härlen H, Schärer K, Spies GW: Statistical report. Proc Eur Dial Transplant Assoc 11: 3, 1974
Carmody M, Cattell WR, Cambi V, Koch KM, Baillod RA: Dialysis—petrified or progressive? Proc Eur Dial Transplant Assoc 11: 537, 1974
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Drukker, W. (1989). Haemodialysis: A Historical Review. In: Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1087-4_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-1087-4_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6979-3
Online ISBN: 978-94-009-1087-4
eBook Packages: Springer Book Archive